Saturday 17 October 2026
Export CABR’s income statement to Excel — free account
Caring Brands, Inc.
CABR Healthcare Drug Manufacturers Specialty & Generic
Caring Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4,200.00, up 740.0% from fiscal 2024. In the quarter to June 2026, EPS fell 102.0% and free cash flow fell 121.3%, each against the same quarter a year earlier.
1.22
0.07
−5.43%
Follow CABR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+4 more quarters Free account |
0.00 | 0.00 | — | — |
P/S ratio |
0.00 | 2,777.62 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(61.69) | (11.00) | — | — | |
P/B ratio |
4.29 | 5.58 | — | — | |
Price to Tangible BV |
0.00 | 0.00 | — | — | |
EV/Sales |
0.00 | 2,270.35 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(12.32) | (5.63) | — | — | |
EV/FCF |
(12.32) | (5.63) | — | — | |
Quick Ratio |
0.03 | 12.38 | 5.29 | 4.73 | |
Current Ratio |
0.08 | 13.16 | 5.65 | 4.97 | |
Net Debt/EBITDA |
0.02 | 0.58 | 1.29 | 2.85 | |
Debt/Assets |
0.06% | 2.52% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.03 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.18 | 0.26 | 0.14 | 0.50 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(51.79) | 6,227.67 | (6.00) | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
142,842.86% | (225,925.00%) | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.83 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 309,675.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.05) | 0.18 | — | — | |
Graham Number |
0.00 | 0.00 | — | — | |
Earnings Yield |
(26.04%) | (53.52%) | — | — | |
Free Cash Flow Yield |
(8.11%) | (14.51%) | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.01) | (0.08) | (0.04) | (0.05) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.01) | (0.08) | (0.04) | (0.05) | |
Cash per Share |
0.00 | 0.16 | 0.14 | 0.20 | |
Shareholders Equity per Share |
0.19 | 0.15 | (0.14) | (0.30) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.19 | 0.15 | (0.14) | (0.30) | |
Free Cash Flow |
(0.18) | (1.06) | (0.55) | (0.46) | |
Working Capital |
(0.52) | 2.15 | 1.79 | 1.53 | |
Net Current Asset Value |
(0.53) | 2.09 | (2.00) | (2.71) | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
— | — | — | 0.23 | |
Average Inventory |
— | — | — | 0.01 | |
Average Assets |
1.59 | 1.16 | 1.09 | 0.95 | |
Average Common Equity |
— | — | — | 0.49 |
Columns are period end dates